CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-12 | Bowden Christopher Chief Medical Officer | Sale | −1,800 | $92.84 | $167K | 1,081 |
| 2018-06-12 | Bowden Christopher Chief Medical Officer | Sale | −200 | $93.37 | $19K | 881 |
| 2018-06-12 | Bowden Christopher Chief Medical Officer | Option exercise · Stock option (right to buy) | −2,000 | 95,000 | ||
| 2018-06-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −3,000 | 19,154 | ||
| 2018-06-05 | Biller Scott Chief Scientific Officer | Option exercise | +3,000 | $9.05 | $27K | 60,196 |
| 2018-06-05 | Biller Scott Chief Scientific Officer | Sale | −802 | $92.45 | $74K | 59,394 |
| 2018-06-05 | Biller Scott Chief Scientific Officer | Sale | −1,259 | $93.27 | $117K | 58,135 |
| 2018-06-05 | Biller Scott Chief Scientific Officer | Sale | −939 | $94.28 | $89K | 57,196 |
| 2018-06-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock options (right to buy) | +3,000 | 19,154 | ||
| 2018-06-01 | Schenkein David P Chief Executive Officer | Option exercise | +12,892 | $0.47 | $6K | 12,892 |
| 2018-06-01 | Schenkein David P Chief Executive Officer | Option exercise | +108 | $2.34 | $253 | 13,000 |
| 2018-06-01 | Schenkein David P Chief Executive Officer | Sale | −1,510 | $94.37 | $142K | 11,490 |
| 2018-06-01 | Schenkein David P Chief Executive Officer | Sale | −8,200 | $95.11 | $780K | 3,290 |
| 2018-06-01 | Schenkein David P Chief Executive Officer | Sale | −3,190 | $96.40 | $308K | 100 |
| 2018-06-01 | Schenkein David P Chief Executive Officer | Sale | −100 | $96.91 | $10K | 0 |
| 2018-06-01 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −12,892 | 0 | ||
| 2018-06-01 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −108 | 72,619 | ||
| 2018-05-31 | Scadden David Director | Grant or award · Stock option (right to buy) | +5,700 | 5,700 | ||
| 2018-05-31 | Scadden David Director | Grant or award · Restricted stock units | +1,400 | 1,400 | ||
| 2018-05-31 | MARAGANORE JOHN Director | Grant or award · Stock option (right to buy) | +5,700 | 5,700 |
Page 60 of 63 · 1,252 trades